Literature DB >> 18180372

The cytoplasmic domain of tissue factor in macrophages augments cutaneous delayed-type hypersensitivity.

Jim Apostolopoulos1, Michael J Hickey, Laveena Sharma, Piers Davenport, Leon Moussa, Will G James, Julia L Gregory, A Richard Kitching, Ming Li, Peter G Tipping.   

Abstract

In addition to its procoagulant role, tissue factor (TF) has important coagulation-independent roles, including in inflammation. The cytoplasmic domain of TF has been implicated in some of these coagulation-independent roles, particularly cell signaling. To assess the contribution of the cytoplasmic domain of TF to cell-mediated adaptive immunity, the development of cutaneous delayed-type hypersensitivity (DTH) was studied in mice lacking the cytoplasmic domain of TF (TF(deltaCT/deltaCT) mice). DTH responses in sensitized mice were significantly attenuated in TF(deltaCT/deltaCT) mice, and leukocyte-endothelial cell interactions, assessed by intravital microscopy, were impaired significantly. Studies in chimeric mice, created by bone marrow transplantation, showed that the absence of the cytoplasmic domain of TF in leukocytes rather than endothelial cells was responsible for reduced DTH and leukocyte recruitment. DTH responses to OVA could be induced in wild-type mice but not in TF(deltaCT/deltaCT) mice by transfer of activated CD4(+) OVA-specific TCR transgenic T cells, demonstrating that the defective DTH response in TF(deltaCT/deltaCT) mice was independent of any defect in T cell activation. Macrophage and neutrophil accumulation and expression of TNF-alpha mRNA and phospho-p38-MAPK were reduced significantly in TF(deltaCT/deltaCT) mice, and their macrophages had reduced P-selectin-binding capacity and reduced in vivo emigration in response to MCP-1. These results indicate that leukocyte expression of the cytoplasmic domain of TF contributes to antigen-specific cellular adaptive immune responses via effects on leukocyte recruitment and activation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18180372     DOI: 10.1189/jlb.0607353

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  7 in total

Review 1.  Protease-activated receptor 2 signaling in inflammation.

Authors:  Andrea S Rothmeier; Wolfram Ruf
Journal:  Semin Immunopathol       Date:  2011-10-06       Impact factor: 9.623

2.  Collagen-induced arthritis is exacerbated in C-reactive protein-deficient mice.

Authors:  Nicholas R Jones; Melissa A Pegues; Mark A McCrory; Steven W Kerr; Huiping Jiang; Rosemarie Sellati; Valentina Berger; Jorge Villalona; Rajvee Parikh; Mary McFarland; Lynn Pantages; Jeffrey B Madwed; Alexander J Szalai
Journal:  Arthritis Rheum       Date:  2011-09

3.  Macrophage migration inhibitory factor and CD74 regulate macrophage chemotactic responses via MAPK and Rho GTPase.

Authors:  Huapeng Fan; Pam Hall; Leilani L Santos; Julia L Gregory; Gunter Fingerle-Rowson; Richard Bucala; Eric F Morand; Michael J Hickey
Journal:  J Immunol       Date:  2011-03-16       Impact factor: 5.422

4.  Hematopoietic tissue factor-protease-activated receptor 2 signaling promotes hepatic inflammation and contributes to pathways of gluconeogenesis and steatosis in obese mice.

Authors:  Jing Wang; Sagarika Chakrabarty; Quyen Bui; Wolfram Ruf; Fahumiya Samad
Journal:  Am J Pathol       Date:  2014-12-02       Impact factor: 4.307

Review 5.  Inflammation, obesity, and thrombosis.

Authors:  Fahumiya Samad; Wolfram Ruf
Journal:  Blood       Date:  2013-10-03       Impact factor: 22.113

Review 6.  The emerging role of coagulation proteases in kidney disease.

Authors:  Thati Madhusudhan; Bryce A Kerlin; Berend Isermann
Journal:  Nat Rev Nephrol       Date:  2015-11-23       Impact factor: 28.314

7.  Tyrosine sulfation of chemokine receptor CCR2 enhances interactions with both monomeric and dimeric forms of the chemokine monocyte chemoattractant protein-1 (MCP-1).

Authors:  Joshua H Y Tan; Justin P Ludeman; Jamie Wedderburn; Meritxell Canals; Pam Hall; Stephen J Butler; Deni Taleski; Arthur Christopoulos; Michael J Hickey; Richard J Payne; Martin J Stone
Journal:  J Biol Chem       Date:  2013-02-13       Impact factor: 5.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.